Allakos Inc (NQ: ALLK )

109.42 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2021 Add to My Watchlist

Price and Volume

Volume	0
Open	109.42
Bid (Size)	105.97 (1)
Ask (Size)	112.61 (1)
Prev. Close	109.42
Today's Range	109.42 - 109.42
52wk Range	75.41 - 157.98
Shares Outstanding	53,996,459
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Allakos Provides Business Update and Reports Second Quarter 2021 Financial Results

August 09, 2021

Allakos Completes Patient Enrollment in Phase 3 Eosinophilic Gastritis and/or Eosinophilic Duodenitis and Phase 2/3 Eosinophilic Esophagitis Clinical Trials of Lirentelimab (AK002)

June 07, 2021

Performance

YTD	-18.20%	-18.20%
1 Month	+25.64%	+25.64%
3 Month	+18.47%	+18.47%
6 Month	-0.57%	-0.57%
1 Year	+41.46%	+41.46%

More News

New Allakos Data Presented at DDW 2021 Suggest that Eosinophilic Gastritis and/or Eosinophilic Duodenitis (EG/EoD) is Highly Underdiagnosed and may be a Common Cause of Moderate-to-Severe Gastrointest

May 24, 2021

Allakos Reports First Quarter 2021 Financial Results and Provides Business Update

May 10, 2021

Allakos Appoints Baird Radford as Chief Financial Officer

April 19, 2021

Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the 2021 DDW Annual Meeting

March 30, 2021

Notable Monday Option Activity: RCEL, DXCM, ALLK

September 20, 2021

Noteworthy Friday Option Activity: CLH, ALLK, MO

September 10, 2021

Allakos Larger Than S&P 500 Component Discovery

September 02, 2021

Sum Up The Parts: ESGV Could Be Worth $86

June 22, 2021

RiverVest Venture Partners Closes $275 Million Life Sciences Fund

March 24, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.